Braxia Scientific (TSE:BRAX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Braxia Scientific, a leader in medical research and ketamine treatments for depression, has announced its annual general and special meeting for shareholders on October 9, 2024. However, the company highlights that shareholders must vote in advance and cannot participate electronically during the meeting. Braxia continues to focus on expanding its innovative mental health treatments and research into new therapeutic methods.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue